MedPath

RIVAROXABAN

RIVAROXABAN

Approved
DIN Number

02547902

Drug Class

Human

Market Date

Dec 13, 2024

Company
HC

sanis health inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02547902
AIG Number0152487001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF01 RIVAROXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIVAROXABANActive
Strength: 10 MG
Monograph: RIVAROXABAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.